Concepedia

Nadège Vimond

NV

17

Publications

2.2K

Citations

16

H-Index

2008

Active since

Affiliations

Inserm(Current)

Institut Gustave Roussy

Nantes Université

Centre National de la Recherche Scientifique

Université Paris-Sud

Nadège Vimond is an author at Inserm specializing in medicine, immunology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2008–2022

17

Publications

17

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Benjamin Besse, Mélinda Charrier, Valérie Lapierre et al. · OncoImmunology · 2015 · 754 citations · Full text

, , +20

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

F Farace, Christophe Massard, Nadège Vimond et al. · British Journal of Cancer · 2011 · 395 citations · Full text

Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

Sylvie Rusakiewicz, Michaëla Semeraro, Matthieu Sarabi et al. · Cancer Research · 2013 · 295 citations · Full text

, , +20

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

Dalil Hannani, Marie Vétizou, David Enot et al. · Cell Research · 2015 · 157 citations · Full text

, , +11

Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma

Valérie Boige, David Malka, Abderrahmane Bourredjem et al. · The Oncologist · 2012 · 132 citations · Full text

Rows per page

1–5 of 17